OrthoPediatrics (NASDAQ:KIDS) PT Raised to $38.00

OrthoPediatrics (NASDAQ:KIDSFree Report) had its price target raised by Truist Financial from $35.00 to $38.00 in a report published on Wednesday, Benzinga reports. Truist Financial currently has a hold rating on the stock.

KIDS has been the subject of a number of other reports. JMP Securities reaffirmed a market outperform rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Tuesday, May 7th. Needham & Company LLC increased their target price on OrthoPediatrics from $37.00 to $42.00 and gave the company a buy rating in a research note on Tuesday, May 7th.

Check Out Our Latest Stock Report on OrthoPediatrics

OrthoPediatrics Trading Down 7.2 %

Shares of KIDS opened at $31.09 on Wednesday. The stock’s fifty day simple moving average is $29.09 and its 200 day simple moving average is $29.18. OrthoPediatrics has a twelve month low of $23.10 and a twelve month high of $48.47. The company has a current ratio of 4.45, a quick ratio of 2.90 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $740.87 million, a P/E ratio of -32.39 and a beta of 1.16.

OrthoPediatrics (NASDAQ:KIDSGet Free Report) last released its quarterly earnings data on Wednesday, March 6th. The company reported ($0.23) EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.05. The company had revenue of $37.61 million for the quarter, compared to the consensus estimate of $37.59 million. OrthoPediatrics had a negative return on equity of 5.12% and a negative net margin of 13.58%. On average, equities research analysts forecast that OrthoPediatrics will post -1.2 earnings per share for the current year.

Insider Transactions at OrthoPediatrics

In related news, insider Joseph W. Hauser sold 2,903 shares of the stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $28.06, for a total value of $81,458.18. Following the completion of the transaction, the insider now owns 52,858 shares of the company’s stock, valued at $1,483,195.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Mark C. Throdahl sold 2,433 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $27.59, for a total transaction of $67,126.47. Following the sale, the director now directly owns 137,857 shares of the company’s stock, valued at approximately $3,803,474.63. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Joseph W. Hauser sold 2,903 shares of the business’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $28.06, for a total transaction of $81,458.18. Following the sale, the insider now owns 52,858 shares of the company’s stock, valued at approximately $1,483,195.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,253 shares of company stock valued at $477,375. 31.80% of the stock is currently owned by insiders.

Hedge Funds Weigh In On OrthoPediatrics

Large investors have recently bought and sold shares of the business. CWM LLC grew its holdings in shares of OrthoPediatrics by 16,283.3% during the fourth quarter. CWM LLC now owns 983 shares of the company’s stock valued at $32,000 after purchasing an additional 977 shares during the last quarter. RiverPark Advisors LLC acquired a new stake in OrthoPediatrics in the third quarter worth $35,000. International Assets Investment Management LLC lifted its stake in OrthoPediatrics by 3,151.4% in the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock valued at $37,000 after buying an additional 1,166 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of OrthoPediatrics by 136.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,341 shares of the company’s stock valued at $107,000 after acquiring an additional 1,927 shares during the period. Finally, State Board of Administration of Florida Retirement System bought a new position in shares of OrthoPediatrics during the first quarter worth about $178,000. Institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

(Get Free Report)

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Articles

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.